Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in rats
Open Access
- 1 February 2022
- journal article
- research article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 231, 109261
Abstract
No abstract availableKeywords
Funding Information
- Sunovion Pharmaceuticals Inc
This publication has 42 references indexed in Scilit:
- Effect of D1-like and D2-like receptor antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine self-administration in ratsBehavioural Pharmacology, 2009
- Dopamine in drug abuse and addiction: results from imaging studies and treatment implicationsMolecular Psychiatry, 2004
- Time Course Analysis of the Discriminative Stimulus Effects of the Optical Isomers of 3,4-Methylenedioxymethamphetamine (MDMA)Pharmacology Biochemistry and Behavior, 1997
- Interaction between Discriminative Stimulus Effects of Cocaine and MorphineThe Japanese Journal of Pharmacology, 1995
- Buspirone and lorazepam abuse liability in humansBehavioural Pharmacology, 1993
- Behavioral pharmacology of tandospirone in baboons: chronic administration and withdrawal, self-injection and drug discriminationDrug and Alcohol Dependence, 1993
- A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutraminePsychopharmacology, 1992
- Abuse Potential of Buspirone and Related DrugsJournal of Clinical Psychopharmacology, 1990
- Studies of dioxole ring substituted 3,4-methylenedioxyamphetamine (MDA) analoguesPharmacology Biochemistry and Behavior, 1989
- Investigation of the abuse liability of buspirone in alcohol-dependent patientsThe American Journal of Medicine, 1986